# Endovascular Therapy for Acute Ischemic Stroke Trial

> **NCT02350283** · PHASE3 · COMPLETED · sponsor: **Ministry of Science and Technology of the People´s Republic of China** · enrollment: 225 (actual)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DEVICE:** Interventional treatment with Solitaire

## Key facts

- **NCT ID:** NCT02350283
- **Lead sponsor:** Ministry of Science and Technology of the People´s Republic of China
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2015-07
- **Final completion:** 2015-12
- **Target enrollment:** 225 (ACTUAL)
- **Last updated:** 2017-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02350283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02350283, "Endovascular Therapy for Acute Ischemic Stroke Trial". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02350283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*